pSivida Corp.
(NASDAQ : PSDV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading PSDV News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.18%165.741.2%$762.85m
INCYIncyte Corporation
0.48%139.641.7%$625.40m
GILDGilead Sciences, Inc.
0.03%67.511.0%$573.84m
CELGCelgene Corporation
0.13%123.381.0%$496.94m
BIIBBiogen Inc.
-0.21%274.821.3%$454.02m
REGNRegeneron Pharmaceuticals, Inc.
2.19%373.002.1%$318.70m
KITEKite Pharma, Inc.
3.14%76.8418.8%$216.10m
ALXNAlexion Pharmaceuticals, Inc.
-0.83%119.261.6%$202.32m
TSROTESARO, Inc.
4.15%160.0016.1%$185.28m
ILMNIllumina, Inc.
1.72%170.583.7%$170.76m
ESPREsperion Therapeutics, Inc.
-3.61%38.9418.7%$166.57m
AUPHAurinia Pharmaceuticals Inc.
-4.41%8.026.3%$143.97m
CLVSClovis Oncology, Inc.
2.61%70.3217.5%$141.44m
VRTXVertex Pharmaceuticals Incorporated
1.04%89.982.2%$134.68m
EXELExelixis, Inc.
2.95%20.917.0%$105.35m

Company Profile

pSivida Corp. develops tiny, sustained-release products, which are designed to deliver drugs and biologics at a controlled and steady rate for weeks, months or years. The company through its technology platforms Duraser and Tethadur is focused on treatment of chronic diseases of the back of the eye and are also exploring applications outside ophthalmology. It is also developing a bioerodible, injectable micro-insert delivering latanoprost to treat glaucoma and ocular hypertension. pSivida was founded by Roger Aston in March 2008 and is headquartered in Waterson, MA.